ro glp-1 tracker launches supply to help patients navigate shortages New Online Tracker May Help

When including all treated participantsthose who completed the trial and those who discontinuedweight loss averaged 23.7%: still substantial, but meaningfully lower than the 28.7% efficacy headline

The glucagon component may also contribute to reduced hepatic lipid accumulation, which improves hepatic insulin sensitivity over time

Lancet 402 (10401), 529544

Tips for subcutaneous injection

People taking GLP-1 drugs like those being prescribed Ozempic were 66% more likely to be diagnosed with gastroparesis, with 0.53% of patients diagnosed about 750 out of nearly 150,000 patients

Community and peer motivation: Join a supportive group of fellow Noomers to share tips, encouragement, and real-world wins